Illumina, Inc. (ILMN)

147.62 +5.97 (+4.21%) USD  |  NASDAQ  |  Jan 20, 15:48
More

Illumina Accounts Receivable (Quarterly): 751.00M for Sept. 30, 2025

Accounts Receivable (Quarterly) Chart

View Accounts Receivable (Quarterly) for ILMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Receivable (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accounts Receivable Definition

View Accounts Receivable Definition
Start Trial

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

View Accounts Receivable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Receivable (Quarterly) Benchmarks

View Accounts Receivable (Quarterly) Benchmarks
Start Trial
Guardant Health, Inc. 115.58M
EXACT Sciences Corp. 306.05M
Natera, Inc. 286.38M
Waters Corp. 748.52M
GeneDx Holdings Corp. 60.94M